Vespa Capital invests in Bluecrest Health
25 July 2019Candesic is proud to have provided the commercial due diligence and strategic guidance that resulted in the 17M GBP investment…ArchiMed acquires Eurolyser Diagnostica
17 July 2019Congratulations to our client ArchiMed on their acquisition of Eurolyser Diagnostica, a fast-growing Austrian IVD player. The announcement follows ArchiMed's…Candesic supports the $450m sale of Blue Earth Diagnostics to Bracco Group
28 June 2019Congratulations to Blue Earth Diagnostics' CEO Jonathan Allis and the management team on this $450M deal. Candesic is proud to…Tikehau invests in Medtrade
13 May 2019Tikehau Capital, through its pan-European growth equity fund, is investing £23m (c. €26m) in Medtrade Products Limited, the UK-based technology-led…General Atlantic acquires minority stake in Doctolib
20 March 2019Congratulations to General Atlantic on their investment in Doctolib. Doctolib is a leading Pan-European digital health player founded in 2013.…Candesic at the center of a strategic children’s care acquisition in the North West
16 January 2019Candesic is proud to have been the Commercial Due Diligence Advisor for Waterland on their acquisition of Sandcastle. Sandcastle provides…
